Product image of Neoprenessa (Perindopril Arginine) supplied by GNH India

Neoprenessa

Active Ingredient:
Perindopril Arginine
Origin:
EU

Neoprenessa (Perindopril Arginine)

Perindopril arginine, the active ingredient in Neoprenessa, is an ACE inhibitor presented as an oral tablet for oral use. It treats hypertension, heart failure and left ventricular dysfunction in adult patients. GNH India supplies Neoprenessa as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Neoprenessa, an ACE inhibitor, is used to manage conditions related to the renin‑angiotensin system.

  • Hypertension: lowers systemic blood pressure by promoting vasodilation.
  • Heart failure: improves cardiac output and reduces symptoms of fluid overload.
  • Left ventricular dysfunction: helps preserve ventricular function and slows disease progression.

How It Works

  • Perindopril arginine inhibits angiotensin‑converting enzyme (ACE), preventing the conversion of angiotensin I to the potent vasoconstrictor angiotensin II. This results in vasodilation, reduced aldosterone secretion, decreased sodium and water retention, and ultimately lower blood pressure and reduced cardiac workload.

Side Effects

Neoprenessa may cause a range of adverse reactions, which are categorised by frequency and severity.

Common Side Effects

  • Cough: dry, persistent throat irritation.
  • Dizziness: especially upon standing.
  • Headache: mild to moderate intensity.
  • Fatigue: general feeling of tiredness.
  • Hypotension: low blood pressure, particularly after the first dose.
  • Nausea: mild gastrointestinal upset.

Serious or Rare Side Effects

  • Angioedema: swelling of face, lips, tongue or airway.
  • Severe hypotension: marked drop in blood pressure causing faintness.
  • Renal impairment: worsening kidney function.
  • Hyperkalemia: elevated blood potassium levels.
  • Neutropenia: reduced white blood cell count.
  • Elevated liver enzymes: signs of hepatic stress.

Precautions & Warnings

When prescribing Neoprenessa, clinicians should consider several precautionary measures.

  • Monitor blood pressure: check regularly, especially after dose changes.
  • Assess renal function: evaluate serum creatinine and eGFR before and during therapy.
  • Check electrolytes: monitor potassium and sodium levels.
  • Avoid in patients with history of angioedema: contraindicated due to risk of recurrence.
  • Use caution in pregnancy: limited data; risk‑benefit assessment required.
  • Store at ambient temperature: keep in the original pack, protect from moisture and light.

Avoid Interactions

Neoprenessa can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid)

  • Aliskiren in diabetic patients: increased risk of renal dysfunction.
  • Potassium‑sparing diuretics or potassium supplements: risk of hyperkalemia.
  • Lithium: elevated lithium concentrations, possible toxicity.

Moderate Interactions (Monitor Closely)

  • NSAIDs: may blunt antihypertensive effect and affect renal function.
  • Thiazide diuretics: can enhance hypotensive response.
  • Other ACE inhibitors or ARBs: additive risk of angioedema and renal impairment.

Frequently Asked Questions

Neoprenessa contains perindopril arginine, an ACE inhibitor indicated for the treatment of hypertension, chronic heart failure, and left ventricular dysfunction. It helps lower blood pressure and improves cardiac function by interfering with the renin‑angiotensin system.

Perindopril arginine blocks the angiotensin‑converting enzyme, reducing the formation of angiotensin II. This leads to vasodilation, decreased aldosterone release, reduced sodium and water retention, and ultimately lower arterial pressure and reduced cardiac workload.

The appropriate dose of Neoprenessa is individualized and must be determined by a qualified prescriber based on the patient’s clinical condition, response to therapy, and any relevant laboratory values. No fixed regimen is provided here.

Safety data for perindopril arginine in pregnancy and lactation are limited. It is generally avoided unless the potential benefit justifies the potential risk to the fetus. Breastfeeding mothers should consult their healthcare provider before use.

To order Neoprenessa, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Neoprenessa (perindopril arginine) belongs to the same class as enalapril, lisinopril and ramipril. All share the core mechanism of ACE inhibition, but pharmacokinetic profiles differ; perindopril is often noted for a once‑daily dosing schedule and a favorable side‑effect profile in some patient populations.

Neoprenessa should be stored at ambient temperature, below 25 °C, in its original container. Protect the tablets from moisture, excessive heat and direct sunlight to maintain potency throughout its shelf life.

Neoprenessa is taken orally, usually with or without food, as directed by the prescribing clinician. The tablet should be swallowed whole with a glass of water and not crushed or chewed unless specifically advised.

The most serious adverse events include angioedema, severe hypotension, acute renal impairment, and marked hyperkalemia. Patients should seek immediate medical attention if they experience swelling of the face or throat, sudden dizziness, reduced urine output, or muscle weakness.

Neoprenessa is contraindicated in patients with a known history of angioedema related to previous ACE‑inhibitor therapy, those with hereditary or idiopathic angioedema, and individuals with severe renal impairment. Caution is also advised for patients with hypotension or electrolyte disturbances.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Perindopril Arginine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT